A phase II biomarker-embedded study of lapatinib plus capecitabine as first-line therapy in patients with advanced or metastatic gastric cancer

Melissa J. LaBonte, Dongyun Yang, Wu Zhang, Peter M. Wilson, Yasir M. Nagarwala, Kevin M. Koch, Colleen Briner, Tomomi Kaneko, Sun Young Rha, Oleg Gladkov, Susan G. Urba, Dina Sakaeva, Michael J. Pishvaian, Ruey Kuen Hsieh, Wei Ping Lee, Heinz Josef Lenz

Research output: Contribution to journalArticle

2 Citations (Scopus)

Fingerprint Dive into the research topics of 'A phase II biomarker-embedded study of lapatinib plus capecitabine as first-line therapy in patients with advanced or metastatic gastric cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences